Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;7(4):259-62.
doi: 10.1080/13651820500373010.

Surgical management of hilar cholangiocarcinoma: the Nagoya experience

Affiliations

Surgical management of hilar cholangiocarcinoma: the Nagoya experience

Hideki Nishio et al. HPB (Oxford). 2005.

Abstract

Of 400 patients with hilar cholangiocarcinoma who were treated at Nagoya University Hospital from 1977 to 2004, 301 (75%) underwent surgical resection. Most patients underwent major hepatectomy with extrahepatic bile duct resection. The overall mortality rate was 7.6% but had decreased to 2.5% in the last 5 years (p=0.007). The overall survival rates at 5, 10 and 15 years were 22%, 13% and 10%, respectively. The survival rates of 233 patients undergoing R0 resection were 27%, 16% and 13%, respectively. R1 or R2 resection, lymph node metastasis and portal vein involvement were significant negative prognostic factors, although survival was better than in patients with unresected tumours. The results show that aggressive surgical treatment of hilar cholangiocarcinoma offers good outcomes with an acceptable mortality rate.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overall survival curves of patients who underwent resection for hilar cholangiocarcinoma (1977–2004). MST, median survival time.
Figure 2.
Figure 2.
Survival curves according to completeness of resection. R0, microscopically radical resection; R1, macroscopically radical resection; R2, macroscopically non-radical resection.
Figure 3.
Figure 3.
Survival curves according to the presence of lymph node metastasis (LNM).
Figure 4.
Figure 4.
Survival curves according to portal vein resection. PVR, portal vein resection and reconstruction.

References

    1. Tashiro S, Tsuji T, Kanemitsu K, Kamimoto Y, Hiraoka T, Miyauchi Y. Prolongation of survival for carcinoma at the hepatic duct confluence. Surgery. 1993;113:270–8. - PubMed
    1. Launois B, Terblanche J, Lakehal M, Catheline JM, Bardax-oglou E, Landen S, et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg. 1999;230:266–75. - PMC - PubMed
    1. Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg. 2000;232:166–74. - PMC - PubMed
    1. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535–44. - PubMed
    1. Nimura Y, Hayakawa N, Kamiya J, Maeda S, Kondo S, Yasui A, et al. Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg. 1991;78:727–31. - PubMed

LinkOut - more resources